Rathbones Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,415
| Closed | -$438K | – | 346 |
|
|
2019
Q3 | $438K | Sell |
4,415
-1,825
| -29% | -$173K | 0.01% | 244 |
|
|
2019
Q2 | $577K | Sell |
6,240
-394
| -6% | -$37.4K | 0.02% | 214 |
|
|
2019
Q1 | $626K | Sell |
6,634
-2,478
| -27% | -$217K | 0.02% | 206 |
|
|
2018
Q4 | $584K | Sell |
9,112
-2,193
| -19% | -$162K | 0.02% | 212 |
|
|
2018
Q3 | $1.01M | Sell |
11,305
-3,737
| -25% | -$330K | 0.03% | 175 |
|
|
2018
Q2 | $1.2M | Sell |
15,042
-6,886
| -31% | -$572K | 0.05% | 155 |
|
|
2018
Q1 | $1.96M | Sell |
21,928
-17,003
| -44% | -$1.63M | 0.08% | 131 |
|
|
2017
Q4 | $4.06M | Sell |
38,931
-2,994
| -7% | -$338K | 0.17% | 94 |
|
|
2017
Q3 | $6.11M | Buy |
41,925
+2,344
| +6% | +$319K | 0.27% | 79 |
|
|
2017
Q2 | $5.14M | Sell |
39,581
-181
| -0.5% | -$22.2K | 0.23% | 88 |
|
|
2017
Q1 | $4.95M | Sell |
39,762
-788
| -2% | -$94.3K | 0.23% | 89 |
|
|
2016
Q4 | $4.69M | Buy |
40,550
+10,523
| +35% | +$1.17M | 0.24% | 82 |
|
|
2016
Q3 | $3.14M | Sell |
30,027
-1,322
| -4% | -$143K | 0.16% | 96 |
|
|
2016
Q2 | $3.09M | Sell |
31,349
-577
| -2% | -$59.7K | 0.17% | 93 |
|
|
2016
Q1 | $3.19M | Sell |
31,926
-595
| -2% | -$61.3K | 0.19% | 84 |
|
|
2015
Q4 | $3.44M | Sell |
32,521
-1,710
| -5% | -$198K | 0.22% | 81 |
|
|
2015
Q3 | $3.7M | Buy |
34,231
+3,218
| +10% | +$399K | 0.25% | 74 |
|
|
2015
Q2 | $3.59M | Buy |
31,013
+240
| +0.8% | +$27.4K | 0.23% | 79 |
|
|
2015
Q1 | $3.55M | Buy |
30,773
+2,508
| +9% | +$300K | 0.23% | 79 |
|
|
2014
Q4 | $3.16M | Sell |
28,265
-239
| -0.8% | -$25.2K | 0.21% | 87 |
|
|
2014
Q3 | $2.7M | Buy |
28,504
+2,910
| +11% | +$263K | 0.19% | 91 |
|
|
2014
Q2 | $2.2M | Sell |
25,594
-850
| -3% | -$64.6K | 0.16% | 98 |
|
|
2014
Q1 | $1.85M | Buy |
26,444
+1,290
| +5% | +$102K | 0.15% | 105 |
|
|
2013
Q4 | $2.13M | Sell |
25,154
-3,696
| -13% | -$292K | 0.21% | 97 |
|
|
2013
Q3 | $2.22M | Buy |
28,850
+8,910
| +45% | +$624K | 0.26% | 86 |
|
|
2013
Q2 | $1.17M | Buy |
+19,940
| New | +$1.2M | 0.16% | 107 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Rathbones Group's CELG Position: Q4 2019 in Review
Rathbones Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,415 shares — an estimated $438K sold.
Rathbones Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.11M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Rathbones Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Rathbones Group sold 4,415 Celgene Corp shares in Q4 2019, an estimated $438K.
- Rathbones Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Rathbones Group's Celgene Corp position peaked at $6.11M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Rathbones Group's 13F filing for Q4 2019, filed 11 Feb 2020.